ResMed Profitability Analysis

RMD Stock  USD 248.69  3.69  1.46%   
Based on the measurements of profitability obtained from ResMed's financial statements, ResMed Inc may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess ResMed's ability to earn profits and add value for shareholders.
 
Net Income  
First Reported
1992-09-30
Previous Quarter
292.2 M
Current Value
311.4 M
Quarterly Volatility
75.4 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
At present, ResMed's Sales General And Administrative To Revenue is projected to slightly decrease based on the last few years of reporting. The current year's Days Of Sales Outstanding is expected to grow to 81.97, whereas EV To Sales is forecasted to decline to 4.22. At present, ResMed's Income Before Tax is projected to increase significantly based on the last few years of reporting. The current year's Net Income is expected to grow to about 1.1 B, whereas Total Other Income Expense Net is projected to grow to (113.4 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.670.5568
Fairly Up
Slightly volatile
Net Profit Margin0.130.2179
Way Down
Very volatile
Operating Profit Margin0.160.2954
Way Down
Slightly volatile
Pretax Profit Margin0.180.27
Way Down
Pretty Stable
Return On Assets0.0960.1486
Way Down
Pretty Stable
Return On Equity0.140.2099
Way Down
Pretty Stable
For ResMed profitability analysis, we use financial ratios and fundamental drivers that measure the ability of ResMed to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well ResMed Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between ResMed's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of ResMed Inc over time as well as its relative position and ranking within its peers.
  

ResMed's Revenue Breakdown by Earning Segment

Check out Your Equity Center.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.416
Dividend Share
1.97
Earnings Share
7.55
Revenue Per Share
32.711
Quarterly Revenue Growth
0.111
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

ResMed Inc Return On Asset vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining ResMed's current stock value. Our valuation model uses many indicators to compare ResMed value to that of its competitors to determine the firm's financial worth.
ResMed Inc is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about  0.56  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ResMed Inc is roughly  1.78 . At present, ResMed's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value ResMed by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

ResMed Return On Asset vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

ResMed

Return On Equity

 = 

Net Income

Total Equity

 = 
0.24
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

ResMed

Return On Asset

 = 

Net Income

Total Assets

 = 
0.13
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.

ResMed Return On Asset Comparison

ResMed is currently under evaluation in return on asset category among its peers.

ResMed Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in ResMed, profitability is also one of the essential criteria for including it into their portfolios because, without profit, ResMed will eventually generate negative long term returns. The profitability progress is the general direction of ResMed's change in net profit over the period of time. It can combine multiple indicators of ResMed, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-251.5 M-239 M
Operating Income1.4 B1.5 B
Income Before Tax1.3 B1.3 B
Total Other Income Expense Net-119.3 M-113.4 M
Net IncomeB1.1 B
Income Tax Expense243.8 M256 M
Net Income Applicable To Common SharesB1.1 B
Net Income From Continuing OpsB526.1 M
Non Operating Income Net Other-32.6 M-30.9 M
Interest Income51.4 M31.4 M
Net Interest Income-45.7 M-43.4 M
Change To Netincome69.4 M45.6 M
Net Income Per Share 6.94  7.29 
Income Quality 1.37  0.96 
Net Income Per E B T 0.81  0.57 

ResMed Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on ResMed. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of ResMed position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the ResMed's important profitability drivers and their relationship over time.

ResMed Profitability Trends

ResMed profitability trend refers to the progression of profit or loss within a business. An upward trend means that ResMed's profit has generally increased over time, and a downward profitability trend means profits are declining. Recognizing problems early in profitability trends allows investors to address revenue and cost issues in advance. Investors and analysts usually monitor three types of profitability trends: gross, operating, and net. Gross profit is the difference between revenue and costs of goods sold. Operating profit is ResMed's gross profit minus its overhead. After you account for other unusual revenue, expenses, and costs, you get net profit. Gross profit trends are often a good indicator of future profitability. If you have high gross profit margins, you have a better chance to cover overhead and make money.

ResMed Profitability Drivers Correlations

One of the toughest challenges investors face today is learning how to quickly synthesize and read into endless financial statements and information provided by the company, SEC reporting, and various external parties. Understanding the correlation between ResMed different financial indicators related to revenue and profit generation helps investors identify and prioritize their investing strategies towards ResMed in a much-optimized way. Analyzing correlations between profit drivers that are directly associated with dollar figures is the most effective way to break down ResMed's future profitability.

Use ResMed in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ResMed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ResMed will appreciate offsetting losses from the drop in the long position's value.

ResMed Pair Trading

ResMed Inc Pair Trading Analysis

The ability to find closely correlated positions to ResMed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ResMed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ResMed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ResMed Inc to buy it.
The correlation of ResMed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ResMed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ResMed Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ResMed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your ResMed position

In addition to having ResMed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Electrical Equipment Thematic Idea Now

Electrical Equipment
Electrical Equipment Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Electrical Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electrical Equipment Theme or any other thematic opportunities.
View All  Next Launch
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:
To fully project ResMed's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of ResMed Inc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include ResMed's income statement, its balance sheet, and the statement of cash flows.
Potential ResMed investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although ResMed investors may work on each financial statement separately, they are all related. The changes in ResMed's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ResMed's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.